The Runway Is Not the Same as Liquidity: Negotiating a Founder Venture Debt Term Sheet

The Runway Is Not the Same as Liquidity: Negotiating a Founder Venture Debt Term Sheet

This post uses hypothetical scenarios for illustrative purposes only. It does not describe any actual client, transaction, or representation, and is not legal advice.

Fictional educational case study. HelioForge Analytics, Inc. and every person, fact, number and transaction described below are fictional. This article illustrates how EF-097 may organize a financing discussion. It is not legal, tax, accounting, investment or financial advice, and it is not a substitute for counsel reviewing the actual deal.

Venture debt can look inexpensive when a team focuses on the headline interest rate. The more useful founder question is whether the complete structure—draw timing, fees, warrant value, amortization, covenants and closing conditions—protects the company’s operating plan when the equity financing arrives later than expected.

This case study follows a founder team through that analysis. It shows how to use the Founder Venture Debt Term Sheet Extended Form (EF-097) as a decision record, not merely a list of economic terms.

The Fictional Company

Item Case fact
Company HelioForge Analytics, Inc., a Delaware corporation
Business Climate-risk analytics sold to infrastructure operators
Stage Series A; approximately $7.2 million annual recurring revenue
Cash at signing $4.6 million
Current net burn $650,000 per month
Equity plan Series B targeted for month 9; downside case assumes month 15
Proposed debt $8 million: $4 million at closing and $4 million delayed draw
Headline pricing Term SOFR plus 8.50%; 1% origination fee; 4% final payment
Equity feature Warrant coverage equal to 5% of funded principal, priced at the next preferred round
Collateral proposal Broad asset lien; core registered intellectual property subject to a negative pledge rather than a present lien

HelioForge wants the facility to extend runway through a Series B. The board initially describes the proposal as “an extra twelve months of runway.” That statement is directionally useful but incomplete. Cash runway measures time at an assumed burn rate. Covenant liquidity measures whether the company remains above a contractual threshold, often after exclusions and subject to testing dates. Debt service and fees also change the burn profile.

The Problem Hidden by the Headline

The lender’s first term sheet offers twelve months of interest-only payments, followed by twenty-four months of amortization. The delayed tranche expires in month 10 and is conditioned on both $10 million of annual recurring revenue and “satisfactory evidence” of a qualified equity financing process. The minimum-liquidity covenant begins in month 7 at $2 million.

Management’s base model assumes the Series B closes in month 9. Under that case, the delayed tranche is available and the company remains comfortably above the liquidity covenant. In the downside case, however, the Series B slips to month 15, the revenue milestone is reached only in month 11, and the delayed tranche has already expired. Amortization begins in month 13. The company can still show more than four months of accounting runway, but it breaches the $2 million liquidity covenant in month 14.

That is the central lesson: runway and covenant headroom are related, but they are not the same calculation.

Why EF-097 Matters

EF-097 makes the team complete the economics and the legal architecture together. For this transaction, the most important controls are:

  • a tranche table showing amount, availability period, objective milestones and documentary conditions;
  • a total-cost schedule that includes fees, final payment, warrant dilution and prepayment economics;
  • a collateral matrix that separates current liens, exclusions, negative pledges and any springing lien;
  • a covenant summary tied to definitions and testing dates; and
  • base, downside and severe-downside runway cases.

The form also records which provisions are intended to be binding. That prevents a nonbinding commercial outline from accidentally obscuring binding confidentiality, exclusivity, expense or governing-law provisions.

How to Complete the Form

Step 1: Build the Facility and Tranche Table

List each tranche separately. For HelioForge, the first row is a $4 million initial advance available at closing. The second row is a $4 million delayed advance. Do not write only “subject to milestones.” State the milestone, the measurement date, the evidence, who determines satisfaction, whether discretion must be reasonable, and what happens if a condition is missed for reasons outside the company’s control.

HelioForge’s team revises the delayed-draw condition from “satisfactory financing process” to an objective package: board-approved operating plan, at least $9.5 million annual recurring revenue measured under the agreed definition, no payment default and delivery of an updated compliance certificate. The availability period moves from month 10 to month 15.

Step 2: Complete the All-In Cost Schedule

The finance team models at least the following:

Cost component Illustrative input Founder question
Initial funded principal $4,000,000 Is interest charged only on funded amounts?
Origination fee $80,000 Is the fee based on committed or funded capital?
Final payment 4% of funded principal Is it due on maturity, prepayment, acceleration or every repayment?
Legal and diligence costs $90,000 cap Is there a cap and an invoice-support requirement?
Warrant coverage 5% of funded principal What valuation or share price determines the number of shares?
Prepayment fee 3% / 2% / 1% Does a refinancing or acquisition trigger it?

The team estimates the warrant’s value using several equity outcomes. That estimate is not presented as a prediction; it is a comparison tool. The board receives both cash cost and dilution scenarios.

Step 3: Test the Payment Timeline

Map interest-only months, amortization start, maturity, final payment and prepayment premiums on the same timeline as the operating model. In HelioForge’s downside case, amortization begins before the Series B. The company asks for an automatic six-month interest-only extension if it reaches $10 million annual recurring revenue and remains above the agreed liquidity level, with no continuing default.

Step 4: Define Liquidity Before Quoting It

“Cash” may exclude restricted cash, cash held outside approved accounts, trapped foreign cash or amounts subject to control restrictions. HelioForge has $600,000 in a foreign subsidiary and a $300,000 processor reserve. The team cannot assume either amount counts.

The term sheet should identify the expected definition and flag it for confirmation in the definitive agreement. The model then uses the same definition. A covenant is not safely analyzed if the spreadsheet and the legal document count different dollars.

Step 5: Separate Current and Contingent IP Rights

The collateral schedule records:

  • assets subject to a present lien;
  • excluded assets and the reason for each exclusion;
  • core IP subject only to a negative pledge;
  • ordinary-course customer and channel licenses that remain permitted; and
  • any objective trigger for a future IP lien.

For HelioForge, the founder team rejects language that could be read as granting a present IP lien while calling it a negative pledge. If the parties later choose a springing lien, the trigger, notice, cure period, activation document and filing mechanics must be explicit.

Step 6: Build the Covenant Headroom Table

The team runs monthly calculations through maturity under three cases:

Month / case Base case cash Downside cash Severe-downside cash Minimum liquidity Result
Month 9 $6.8M $4.1M $3.3M $2.0M Pass in all cases
Month 13 $7.4M $2.7M $1.9M $2.0M Severe case fails
Month 15 $8.1M $1.8M $0.9M $2.0M Downside and severe cases fail

This does not tell the board whether to accept the deal. It tells the board where negotiation, contingency planning or additional equity support is needed.

Step 7: Record Binding Terms and Open Items

The signature section should identify which provisions are binding and which remain subject to definitive documentation. The open-items list should name an owner and deadline for every unresolved point, including warrant pricing, milestone evidence, IP treatment, expense cap, account-control timing and any investor approval.

The Negotiated Result

HelioForge does not simply demand “more flexibility.” It proposes measurable alternatives:

  • a month-15 delayed-draw expiration;
  • a revenue milestone defined by the company’s consistently applied subscription policy;
  • a six-month interest-only extension upon an objective performance test;
  • a $2 million minimum-liquidity covenant that begins only after the second tranche is funded;
  • a capped expense reimbursement supported by invoices;
  • a negative pledge over core IP with no present grant language; and
  • a warrant share-price mechanism with a valuation cap and a maximum share count.

The lender accepts some points and modifies others. The final term sheet still requires counsel to translate the business deal into definitive documents, but the board now understands the tradeoffs it approved.

Risk-Control Table

Issue What can go wrong EF-097 control Specialist or approval gate
Delayed draw Capital expires before it is needed Objective milestone and availability table CFO model; lender confirmation
Liquidity covenant Company counts cash the agreement excludes Defined-term and headroom review Finance and transaction counsel
Warrant dilution Coverage looks small but converts into excessive shares Scenario table, cap and share-price mechanics Board, investor-rights and tax review
IP package “Negative pledge” language grants a present lien Separate collateral choices and activation mechanics IP and secured-transactions counsel
Fees Final payment or expenses apply more broadly than expected All-in cost schedule Finance and counsel
Exclusivity Company loses financing alternatives too early Binding-term inventory and expiration Board and counsel

Common Mistakes

  • Modeling interest but omitting final payments, legal expenses and warrants.
  • Treating an undrawn commitment as if it were unrestricted cash.
  • Accepting milestones that depend on unbounded lender discretion.
  • Describing the liquidity covenant without reproducing its operative definition.
  • Allowing the delayed-draw period to end before the downside financing date.
  • Failing to cap warrant shares or address stock splits and future financing prices.
  • Assuming the term sheet’s collateral summary will automatically be preserved in the loan agreement.
  • Signing exclusivity before the board understands the alternatives and closing path.

Questions for the Founder and Board

  1. What event is the debt financing intended to bridge, and how late can that event occur?
  2. Does each draw condition depend on facts the company can measure and prove?
  3. What is the lowest monthly covenant headroom in the downside case?
  4. What cash is excluded from the liquidity definition?
  5. When does amortization begin relative to the expected equity financing?
  6. What is the maximum cash cost and maximum potential dilution?
  7. Which assets are subject to present liens, negative pledges or contingent liens?
  8. What approvals, consents or waivers are required before signing or funding?

AI-Assisted Completion Workflow

An AI tool can help organize the first pass, but it should not decide legal positions or certify facts. Provide the board-approved operating model, capitalization table, proposed term sheet, charter, investor-rights documents, existing debt schedule and IP summary. Remove secrets that the tool is not authorized to receive.

Use an instruction such as:

Using only the supplied materials, prepare a completion draft of EF-097. Separate quoted terms from assumptions. Build facility, cost, collateral, covenant and approval tables. Calculate no legal conclusions. Flag inconsistent definitions, missing evidence, discretionary conditions, uncapped economics and any term that requires board, investor, tax, IP or secured-transactions review. Do not invent facts. Return an open-items list with an owner and source for every unresolved entry.

Human reviewers should trace every populated fact to a source, independently verify calculations and compare the signed term sheet against the definitive documents.

Do Not Use This Approach When

Do not use a term-sheet completion exercise as a substitute for definitive-document review, solvency analysis, tax advice, regulatory advice, fiduciary analysis or approval under the company’s governing documents. A distressed company, regulated borrower, cross-border group, company with material government grants, or company pledging licensed or jointly owned IP requires additional specialist work.

What the Team Should Do Next

After the term sheet is approved, transfer each negotiated point into a definitive-document issues list. Build the loan agreement, disclosure schedules, perfection certificate, board and investor approvals, funding certificate and closing checklist from the same verified data set. Assign an owner for each condition and preserve the approved model as part of the board record.

Related Form

This case study accompanies EF-097 — Founder Venture Debt Term Sheet Extended Form, part of the firm’s fundraising and investor forms. Use the reviewed Word form for matter work; use this article as a teaching and issue-spotting guide.

Website Posting Disclaimer

This publication is general educational information based on a fictional scenario. It does not create an attorney-client relationship and should not be relied on as legal advice. Financing terms, enforceability, perfection, tax consequences, fiduciary duties and required approvals depend on the actual documents, facts and jurisdictions. Engage qualified counsel before negotiating, approving, signing or funding any transaction.

If you are negotiating a venture debt term sheet and want the full cash and equity cost modeled before you sign, feel free to reach out to our firm manager, Magda, at Magda@montague.law, or fill out our contact form. Mention you read this post.

Legal Disclaimer

The information provided in this article is for general informational purposes only and should not be construed as legal or tax advice. The content presented is not intended to be a substitute for professional legal, tax, or financial advice, nor should it be relied upon as such. Readers are encouraged to consult with their own attorney, CPA, and tax advisors to obtain specific guidance and advice tailored to their individual circumstances. No responsibility is assumed for any inaccuracies or errors in the information contained herein, and John Montague and Montague Law expressly disclaim any liability for any actions taken or not taken based on the information provided in this article.

Contact Info

Address: 5472 First Coast Hwy #14
Fernandina Beach, FL 32034

Phone: 904-234-5653

More Articles